文献速递神经技术与安全MR

脑肿瘤、脑血管病和痴呆患者动态磁敏感对比灌注的标准化采集与后处理:后处理软件的可比性

Standardized acquisition and post-processing of dynamic susceptibility contrast perfusion in patients with brain tumors, cerebrovascular disease and dementia: comparability of post-processing software.
PubMed 文献 · Br J Radiol · 2019-10-24

本研究分析260例脑肿瘤、脑血管病和痴呆患者在同一MR协议下采集的动态磁敏感对比灌注数据,分别用Olea sphere和NordicICE两款软件处理。结果显示即使采用高度标准化流程,各疾病组灌注参数在两款软件间仍存在显著差异,放射科医生在临床和科研中应考虑软件相关变异。

要点

  • 同一DSC灌注原始数据经Olea sphere与NordicICE处理后,正常脑组织及病变区的MTT、rBF、rBVc等参数均存在显著差异。
  • 软件间差异在脑肿瘤、脑血管病和痴呆患者中均存在,报告灌注参数时应注明所用后处理软件。
  • 即使高度标准化采集与处理流程,参数图仍依赖所选软件,临床解读和科研对比需考虑软件相关变异。

核心结论

  • 尽管采用高度标准化的工作流程,参数灌注图仍取决于所选软件。
  • 放射科医生在临床影像和科研中使用动态磁敏感对比灌注时应考虑软件相关变异。

研究设计与样本

  • 多中心研究,纳入260例患者,其中脑肿瘤80例、脑血管病124例、痴呆56例,均采用同一MR协议检查。
  • 原始数据分别用Olea sphere和NordicICE两款软件处理,组间差异采用配对t检验和单因素方差分析。

诊断标准与关键数值

  • 正常脑组织左半球皮层/白质比值:MTT 0.991 vs 0.847(p<0.05),rBF 3.23 vs 4.418(p<0.001),rBVc 2.813 vs 3.884(p<0.001)。
  • 正常脑组织右半球皮层/白质比值:MTT 1.079 vs 0.854(p<0.05),rBF 3.262 vs 4.378(p<0.001),rBVc 2.762 vs 3.935(p<0.001)。
  • 卒中患者患侧半球皮层/白质比值MTT 1.058 vs 0.784(p<0.001)。
  • 痴呆患者左半球皮层/白质比值rBVc 1.152 vs 1.795(p<0.001),右半球rBVc 1.396 vs 1.662(p<0.05)。
  • 脑肿瘤患者皮层/全肿瘤rBVc比值0.778 vs 0.919(p<0.001),皮层/肿瘤热点rBVc比值0.529 vs 0.512(p<0.05)。

临床应用与阅片要点

  • 报告DSC灌注参数时应注明所用后处理软件,避免跨软件直接比较绝对值。
  • 同一患者随访或同一研究内应使用同一软件处理,以减少软件相关变异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: MR-perfusion post-processing still lacks standardization. This study evaluates the results of perfusion analysis with two established software solutions in a large series of patients with different diseases when a highly standardized processing workflow is ensured.

METHODS: Multicenter data of 260 patients (80 with brain tumors, 124 with cerebrovascular disease and 56 with dementia examined with the same MR protocol) were analyzed. Raw data sets were processed with two software suites: Olea sphere and NordicICE. Group differences were analyzed with paired t-tests and one-way ANOVA.

RESULTS: Perfusion metrics were significantly different for all examined diseases in the unaffected brain for both software suites [ratio cortex/white matter left hemisphere: mean transit time (MTT) 0.991 vs 0.847, p < 0.05; relative cerebral bloodflow (rBF) 3.23 vs 4.418, p < 0.001; relative cerebral bloodvolume (rBVc) 2.813 vs 3.884, p < 0.001; right hemisphere: MTT 1.079 vs 0.854, p < 0.05; rBF 3.262 vs 4.378, p < 0.001; rBVc 2.762 vs 3.935, p < 0.001)]. Perfusion results were also significantly different in patients with stroke (ratio cortex/white matter affected hemisphere: MTT 1.058 vs 0.784; p < 0.001), dementia (ratio cortex/white matter left hemisphere: rBVc 1.152 vs 1.795, p < 0.001; right hemisphere: rBVc 1.396 vs 1.662, p < 0.05) and brain tumors (ratio cortex/whole tumor rBVc: 0.778 vs 0.919, p < 0.001 and ratio cortex/tumor hotspot rBVc: 0.529 vs 0.512, p < 0.05).

CONCLUSION: Despite a highly standardized workflow, parametric perfusion maps are depended on the chosen software. Radiologists should consider software related variances when using dynamic susceptibility contrast perfusion for clinical imaging and research.

ADVANCES IN KNOWLEDGE: This multicenter study compared perfusion parameters calculated by two commercial dynamic susceptibility contrast perfusion post-processing software solutions in different central nervous system disorders with a large sample size and a highly standardized processing workflow. Despite, parametric perfusion maps are depended on the chosen software which impacts clinical imaging and research.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Schmidt MA, Knott M, Hoelter P, et al. Standardized acquisition and post-processing of dynamic susceptibility contrast perfusion in patients with brain tumors, cerebrovascular disease and dementia: comparability of post-processing software. Br J Radiol. 2019. PMID: 31617743. doi:10.1259/bjr.20190543

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。